AstraZeneca Annual Report and Form 20-F Information 2008

World Markets

The world pharmaceutical market in 2008 was valued at $689 billion – an increase of 5% at CER (2007: 7%). Overall growth was constrained by a significant slow-down in the US even though growth in other Established ROW was maintained and growth in Emerging ROW, in particular Emerging Asia Pacific, was strong.

Despite its slower growth, the US remains the largest pharmaceutical market in the world, representing 42% of the global sales total (2007: 46%). The order of the top ten countries ranked by market size did not change in 2008 but, Poland, Australia and Turkey moved up the overall top 20 rankings.

WORLD PHARMACEUTICAL MARKETS

		Sales $bn	Growth %	Market value %
Emerging ROW 2008		108	14	16
2007		87	13	14
2006		74	12	13
Established ROW 2008		271	5	39
2007		232	4	37
2006		211	4	37
North America 2008		310	2	45
2007		304	7	49
2006		284	7	50

Data based on world market sales using AstraZeneca market definitions as set out in the glossary.

WORLD RANKINGS BY COUNTRY

	Rank  MAT/Q3/08	Rank  MAT/Q3/07	Growth  MAT/Q3/08  %	Growth  MAT/Q3/07  %	Market Share  MAT/Q3/08  %	Sales  MAT/Q3/08  $bn
US	1	1	1	7	42	291
Japan	2	2	4	2	9	65
France	3	3	4	5	6	43
Germany	4	4	6	3	6	42
Italy	5	6	4	–	4	26
UK	6	5	2	5	3	23
Spain	7	7	8	8	3	23
Canada	8	8	6	7	3	19
China1	9	9	27	21	3	18
Brazil2	10	10	12	10	2	13
Turkey2	11	13	9	18	2	10
South Korea	12	11	11	10	1	10
Australia	13	14	11	8	1	9
Mexico2	14	12	4	8	1	9
India2	15	15	13	13	1	7
Poland	16	17	9	8	1	7
Netherlands	17	16	5	8	1	7
Belgium	18	18	8	4	1	6
Greece2	19	19	12	18	1	6
Sweden	20	20	6	6	1	4

Data based on world retail and hospital pharmacy sales except:
¹Hospital pharmacy only
²Retail pharmacy only
MAT = Moving Annual Total
Source: IMS Health 2008 MIDAS Quantum

Back to the top